Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Halabi

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
JAMA Oncology|November 20, 2025
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active SurveillanceMatthew R Cooperberg, John R Bihn, John M Culnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
JAMA Network Open|November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
The Journal of Clinical Investigation|November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
JAMA Oncology|November 20, 2025
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active SurveillanceMatthew R Cooperberg, John R Bihn, John M Culnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
JAMA Network Open|November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
The Journal of Clinical Investigation|November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Pageof 29